Romina Boccia and Dominik Lett Congress is barreling toward a March 14 discretionary funding deadline with no agreement in sight. Republicans are aiming to pass yet another stopgap funding patch…
Investing
-
-
Alex Nowrasteh The Trump administration is preparing several travel and immigration bans for people from different countries that could be implemented as soon as this week. On inauguration day, the…
-
James A. Dorn President Trump likes to say, “The word tariff is the most beautiful word in the dictionary”; tariffs “make our country rich” and “cost Americans nothing.” Yet, nothing could…
-
Jeffrey A. Singer In an interview by ABC News’ Jonathan Karl on March 9, White House National Economic Council Director Kevin Hassett said of President Trump’s tariffs on products imported…
-
Stephen Slivinski and Yasmeen Kallash-Kyler Housing policy reform is tricky. Getting policy changes off the ground in the first place can be difficult and compliance after enactment may not be…
-
Editor's PickInvesting
Trump’s Tariff Walkback Bows to Economic Reality but Leaves Plenty of Problems
Alfredo Carrillo Obregon and Scott Lincicome On March 6, President Donald Trump exempted Canadian and Mexican imports that enter the US free of duty under the US-Mexico-Canada Agreement (USMCA) from the…
-
Editor's PickInvesting
The FDA Finally Removes a Huge Barrier to an Effective Schizophrenia Medicine
Jeffrey A. Singer As Josh Bloom and I wrote last November, the Food and Drug Administration (FDA) imposed onerous requirements on health care providers prescribing the effective drug clozapine to…
-
Colleen Hroncich Remote pandemic schooling wasn’t working for her second-grade daughter, so Rebecca Simmons decided it was a good time to start homeschooling. “I was supplementing her work anyway,” she…
-
Jeffrey Miron and Jacob Winter Much debate exists about whether the US tax and transfer system unfairly benefits wealthy people at the expense of ordinary Americans. For example, Democratic members…
-
Editor's PickInvesting
Evaluating PDUFA: Paying for FDA Drug-Application Reviewers by Charging User Fees
Michael F. Cannon A congressional staffer recently asked about the performance of the Food and Drug Administration (FDA), including the Prescription Drug User Fee Act (PDUFA). Since 1992, PDUFA has…